Taburet, Anne-Marie <br/><br/>
Interactions between amprenavir and the lopinavir-ritonavir combination in heavily pretreated patients infected with human immunodeficiency virus.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  Apr 2004 
 - 310-23 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0009-9236 
<br/><br/><label>Standard No.: </label>10.1016/j.clpt.2003.12.013  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Antiretroviral Therapy, Highly Active<br/>Biological Availability<br/>Carbamates<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Drug Interactions<br/>Drug Therapy, Combination<br/>Female<br/>Follow-Up Studies<br/>Furans<br/>HIV Infections--diagnosis<br/>Humans<br/>Lopinavir<br/>Male<br/>Maximum Tolerated Dose<br/>Middle Aged<br/>Probability<br/>Pyrimidinones--administration & dosage<br/>Risk Assessment<br/>Ritonavir--administration & dosage<br/>Salvage Therapy<br/>Severity of Illness Index<br/>Single-Blind Method<br/>Statistics, Nonparametric<br/>Sulfonamides--administration & dosage<br/>Survival Rate<br/>Treatment Outcome<br/>Viral Load